Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRHa Combined with Vaginal Repair for Cesarean Scar Diverticula
NCT02932761Unknown
- Start
- Nov 2016
- Primary completion
- Jan 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of goserelin in cesarean scar defect (CSD) (2 arms). Primary endpoints: thickness of the remaining muscular layer at 6 months and duration of menstruation at 6 months. Status: unknown.
02
Drugs
goserelin
03
Conditions
cesarean scar defect (CSD)
Beyond the preview
Go deeper on NCT02932761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02932761.